Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Linya Wang
Institution:
Twist Bioscience (United States)
Observed institution:
Twist Bioscience (United States)
ORCID:
0009-0008-6816-215X
Observed ORCID:
0009-0008-6816-215X
OpenAlex ID:
A5063110352
Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries
2021
·
Tom Z. Yuan
, Pankaj Garg
, et al.
·
mAbs
·
31
PDF
Functional GLP-1R antibodies identified from a synthetic GPCR-focused library demonstrate potent blood glucose control
2021
·
Qiang Liu
, Pankaj Garg
, et al.
·
mAbs
·
24
PDF
Optimization of a Glucagon-Like Peptide 1 Receptor Antagonist Antibody for Treatment of Hyperinsulinism
2023
·
Sean M. Peterson
, Christine A. Juliana
, et al.
·
Diabetes
·
8
PDF
Discovery of a potent, selective, and tumor-suppressing antibody antagonist of adenosine A2A receptor
2024
·
Linya Wang
, Pankaj Garg
, et al.
·
PLoS ONE
·
5
A multi-faceted discovery strategy identifies functional antibodies binding to cysteine-rich domain 1 of hDKK1 for cancer immunotherapy via Wnt non-canonical pathway
2025
·
Linya Wang
, Sean M. Peterson
, et al.
·
Oncogene
·
3
PDF
Optimization of a glucagon-like peptide 1 receptor antagonist antibody for treatment of hyperinsulinism
2023
·
Sean M. Peterson
, Christine A. Juliana
, et al.
·
1
PDF
A multi-faceted discovery strategy identifies functional Dickkopf-1 antibodies binding to cysteine-rich domain 1 of hDKK1 for cancer immunotherapy via Wnt non-canonical pathway 2061
2025
·
Linya Wang
, Sean M Peterson
, et al.
·
The Journal of Immunology
PDF
Abstract 5793: Functional DKK1 antibodies binding to cysteine-rich domain 1 or 2 of hDKK1 demonstrate antagonistic activities on tumor suppression or TCF/LEF signaling
2024
·
Linya Wang
, Zhen Han
, et al.
·
Cancer Research
Functional DKK1 antibodies demonstrate antagonistic and tumor suppression activities
2023
·
Linya Wang
, Sean Michael Peterson
, et al.
·
The Journal of Immunology
PDF
Abstract 2649: Discovery of a potent, selective, and tumor-suppressing antibody antagonist of DKK1
2023
·
Linya Wang
, Sean M. Peterson
, et al.
·
Cancer Research
Abstract 1531: Human anti-CD40 agonistic antibodies with enhanced FcgR engagement activate immune cell and promote anti-tumor efficacy
2023
·
Linya Wang
, Tom Z. Yuan
, et al.
·
Cancer Research
Abstract P052: Functional ADORA2A antibodies demonstrates the antagonistic and tumor suppression activities
2022
·
Linya Wang
, Ana Lujan
, et al.
·
Cancer Immunology Research
Show more works
View as search
Works count:
12
Citation count:
72
H-index:
4
I10-index:
2
Year
Topic
Type
